MONTE ROSA THERAPEUTICS
Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways. Its rational approach in targeting disease-causing proteins for degradation will deliver pioneering therapies for cancer and beyond.
MONTE ROSA THERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Founded:
2018-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.monterosatx.com
Total Employee:
51+
Status:
Active
Contact:
917-363-0113
Email Addresses:
[email protected]
Total Funding:
223.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Google Tag Manager WordPress Wordpress Plugins Nginx Sitelinks Search Box
Similar Organizations
Aukera Therapeutics
Aukera Therapeutics is a biotech company that develops novel therapeutics for patients suffering from mTOR protein related diseases.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Advisors List
Current Employees Featured
Stock Details
Investors List
Amzak Health Investors
Amzak Health Investors investment in Series C - Monte Rosa Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Monte Rosa Therapeutics
Avoro Capital Advisors
Avoro Capital Advisors investment in Series C - Monte Rosa Therapeutics
Cambridge Asset Management
Cambridge Asset Management investment in Series C - Monte Rosa Therapeutics
RTW Investments LLC
RTW Investments LLC investment in Series C - Monte Rosa Therapeutics
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series C - Monte Rosa Therapeutics
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series C - Monte Rosa Therapeutics
GV
GV investment in Series C - Monte Rosa Therapeutics
Aisling Capital
Aisling Capital investment in Series C - Monte Rosa Therapeutics
New Enterprise Associates
New Enterprise Associates investment in Series C - Monte Rosa Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-02 | Monte Rosa Therapeutics Appoints Jullian G. Jones, Ph.D., J.D., MBA, as Chief Business Officer |
Official Site Inspections
http://www.monterosatx.com Semrush global rank: 1.43 M Semrush visits lastest month: 19.57 K
- Host name: 191.103.223.35.bc.googleusercontent.com
- IP address: 35.223.103.191
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
